Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Takagi, Shinsuke"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-5 z 5
    Tytuł:
    A Case of Closed Pilon Fracture Resulting in Soft-Tissue Necrosis and Treated with Reverse Sural Artery Flap and Circular External Fixation.
    Autorzy:
    Igaki R; Department of Orthopaedic Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
    Yasuda T; Department of Orthopaedic Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
    Samejima Y; Department of Orthopaedic Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
    Irie Y; Department of Orthopaedic Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
    Murakami Y; Department of Orthopaedic Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
    Yoneya T; Department of Orthopaedic Surgery, Yokohama Shintoshi Neurosurgical Hospital, Yokohama, Japan.
    Takagi S; Department of Plastic and Reconstructive Surgery, Showa University School of Medicine, Tokyo, Japan.
    Kawasaki K; Department of Orthopaedic Surgery, Showa University Northern Yokohama Hospital, Yokohama, Japan.
    Kanzaki K; Department of Orthopaedic Surgery, Showa University Fujigaoka Hospital, Yokohama, Japan.
    Pokaż więcej
    Źródło:
    Case reports in orthopedics [Case Rep Orthop] 2023 Aug 09; Vol. 2023, pp. 9222479. Date of Electronic Publication: 2023 Aug 09 (Print Publication: 2023).
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Rituximab/bendamustine/cytarabine for transplant-eligible patients with mantle cell lymphoma: A retrospective study.
    Autorzy:
    Shimizu Y; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Kaji D; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Watanabe O; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Yamaguchi K; Department of Hematology, Toranomon Hospital, Kajigaya, Japan.
    Kageyama K; Department of Hematology, Toranomon Hospital, Kajigaya, Japan.
    Taya Y; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Nishida A; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Ishiwata K; Department of Hematology, Toranomon Hospital, Kajigaya, Japan.
    Takagi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Yamamoto H; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Mori YA; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Wake A; Department of Hematology, Toranomon Hospital, Kajigaya, Japan.
    Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Taniguchi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Yamamoto G; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (11), pp. 12548-12552. Date of Electronic Publication: 2023 May 18.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Lymphoma, Mantle-Cell*/drug therapy
    Lymphoma, Mantle-Cell*/pathology
    Hematopoietic Stem Cell Transplantation*
    Adult ; Humans ; Rituximab/adverse effects ; Retrospective Studies ; Bendamustine Hydrochloride/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Transplantation, Autologous ; Cyclophosphamide/adverse effects ; Prednisone/adverse effects ; Vincristine/adverse effects ; Cytarabine/adverse effects ; Doxorubicin/adverse effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Autorzy:
    Kimura M; Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. .
    Araoka H; Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
    Yoshida A; Department of Infection Control and Clinical Laboratory Medicine, Dokkyo Medical University, Tochigi, Japan.
    Yamamoto H; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Abe M; Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
    Okamoto Y; Department of Infection Control and Clinical Laboratory Medicine, Dokkyo Medical University, Tochigi, Japan.
    Yuasa M; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Kaji D; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Kageyama K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Nishida A; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Ishiwata K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Takagi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Yamamoto G; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Asano-Mori Y; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Hishinuma A; Department of Infection Control and Clinical Laboratory Medicine, Dokkyo Medical University, Tochigi, Japan.
    Izutsu K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Wake A; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Taniguchi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
    Yoneyama A; Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
    Pokaż więcej
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2016 Aug 05; Vol. 16, pp. 372. Date of Electronic Publication: 2016 Aug 05.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Bacteremia/*drug therapy
    Hematologic Neoplasms/*therapy
    Hematopoietic Stem Cell Transplantation/*adverse effects
    Levofloxacin/*therapeutic use
    Streptococcal Infections/*prevention & control
    Viridans Streptococci/*isolation & purification
    Adult ; Aged ; Antibiotic Prophylaxis/methods ; Bacteremia/epidemiology ; Bacteremia/microbiology ; Female ; Hematologic Neoplasms/complications ; Hematologic Neoplasms/epidemiology ; Hospitals ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Retrospective Studies ; Streptococcal Infections/epidemiology ; Streptococcal Infections/microbiology ; Transplantation Conditioning/methods ; Transplantation, Homologous ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'.
    Autorzy:
    Araoka H; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
    Baba M
    Takagi S
    Matsuno N
    Ishiwata K
    Nakano N
    Tsuji M
    Yamamoto H
    Seo S
    Asano-Mori Y
    Uchida N
    Masuoka K
    Wake A
    Taniguchi S
    Yoneyama A
    Pokaż więcej
    Źródło:
    Scandinavian journal of infectious diseases [Scand J Infect Dis] 2010 Mar; Vol. 42 (3), pp. 231-3.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Drug Resistance, Multiple, Bacterial*
    Aminoglycosides/*therapeutic use
    Anti-Bacterial Agents/*therapeutic use
    Monobactams/*therapeutic use
    Pseudomonas Infections/*drug therapy
    Pseudomonas aeruginosa/*drug effects
    beta-Lactamases/*biosynthesis
    Drug Therapy, Combination/methods ; Female ; Humans ; Japan ; Male ; Microbial Sensitivity Tests/methods ; Middle Aged ; Pseudomonas Infections/microbiology ; Pseudomonas aeruginosa/isolation & purification ; Sepsis/drug therapy ; Sepsis/microbiology ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML.
    Autorzy:
    Saito Y; Research Unit for Human Disease Models, RIKEN Research Center for Allergy and Immunology, Yokohama, Japan.
    Uchida N
    Tanaka S
    Suzuki N
    Tomizawa-Murasawa M
    Sone A
    Najima Y
    Takagi S
    Aoki Y
    Wake A
    Taniguchi S
    Shultz LD
    Ishikawa F
    Pokaż więcej
    Źródło:
    Nature biotechnology [Nat Biotechnol] 2010 Mar; Vol. 28 (3), pp. 275-80. Date of Electronic Publication: 2010 Feb 14.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cell Cycle/*drug effects
    Granulocyte Colony-Stimulating Factor/*pharmacology
    Leukemia, Myeloid, Acute/*drug therapy
    Leukemia, Myeloid, Acute/*pathology
    Neoplastic Stem Cells/*drug effects
    Neoplastic Stem Cells/*pathology
    Animals ; Apoptosis/drug effects ; Cell Differentiation/drug effects ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Leukemia, Myeloid, Acute/metabolism ; Mice ; Mice, SCID ; Neoplastic Stem Cells/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-5 z 5

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies